News
Joe Biden's prostate cancer, marked by a high Gleason score and bone metastasis, is likely to be hormone-sensitive. Experts speak about treatment strategies and prognosis.
8d
MedPage Today on MSNNon-Hormonal Drug Reduced Hot Flashes From Endocrine Therapy for Breast CancerCHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...
As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a new study sheds ...
Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2 ...
A study led by Cancer Center at Illinois (CCIL) member Jason Ridlon, associate professor of animal sciences in the College of ...
Pluvicto demonstrated positive results in patients with PSMA-positive metastatic hormone-sensitive prostate cancer.
8d
MedPage Today on MSNPARP-ARPI Combo Sets New Standard for Metastatic Hormone-Sensitive Prostate Cancer"PARP inhibitors have been a mainstay in the treatment of metastatic castration-resistant prostate cancer for patients with ...
Dr. Alicia Morgans discussed complications associated with ADT in prostate cancer, and how men can still maintain quality of ...
A “breakthrough” new three-drug combination offers hope for women battling an aggressive form of breast cancer, potentially ...
Former president Joe Biden said he’s optimistic about his treatment in his first comments since his office revealed he has an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results